Severe or decompensated obstructive sleep apnoea syndrome (OSAS) was significantly associated with functional hypogonadism in men with severe obesity. Continuous positive airway pressure (CPAP) ...
A treatment commonly used for obstructive sleep apnoea (OSA), lowers the risk of serious cardiovascular events in some patients but not others, according to research published in the European Heart ...
The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...
Sleep apnea affects more than 30 million Americans, making it one of the most prevalent sleep disorders in the United States. Continuous Positive Airway Pressure (CPAP) therapy has emerged as the ...
Twenty-five million—that’s the number of adults in the U.S. suffering from Obstructive Sleep Apnea (OSA), a condition that can range from mild difficulty breathing during sleep to a fatal condition, ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results